Legend Biotech USA Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$150.5M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Legend Biotech USA's estimated annual revenue is currently $52.7M per year.(?)
  • Legend Biotech USA's estimated revenue per employee is $155,000
  • Legend Biotech USA's total funding is $150.5M.

Employee Data

  • Legend Biotech USA has 340 Employees.(?)
  • Legend Biotech USA grew their employee count by 50% last year.
  • Legend Biotech USA currently has 22 job openings.

Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.